SARAH TAYLOR: Open Payments
NPI 1962913723 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 17 payments from 8 companies in 2025. Trend: 2023 $595 · 2024 $525 · 2025 $572
Food & beverage: $467Education: $105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $271 |
| Janssen Biotech, Inc. | 1 | $95 |
| UCB, Inc. | 2 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Biofrontera Inc. | 1 | $25 |
| LEO Pharma Inc. | 1 | $24 |
| Amgen Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: BOTOX, TREMFYA, SKYRIZI, Bimzelx, DUPIXENT, RINVOQ, ANZUPGO, Otezla.
Industry payments across CA — which companies pay providers there.
